ZARBO, Ignazio Roberto
 Distribuzione geografica
Continente #
NA - Nord America 1.824
AS - Asia 1.258
SA - Sud America 1.121
EU - Europa 628
AF - Africa 60
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 4.898
Nazione #
US - Stati Uniti d'America 1.764
BR - Brasile 1.009
SG - Singapore 579
CN - Cina 312
UA - Ucraina 137
DE - Germania 127
HK - Hong Kong 111
IT - Italia 102
VN - Vietnam 68
SE - Svezia 44
GB - Regno Unito 41
FI - Finlandia 37
AR - Argentina 33
BD - Bangladesh 29
MX - Messico 28
RU - Federazione Russa 28
ZA - Sudafrica 28
IQ - Iraq 26
TR - Turchia 23
CA - Canada 22
CZ - Repubblica Ceca 21
EC - Ecuador 21
FR - Francia 20
VE - Venezuela 19
PK - Pakistan 16
UZ - Uzbekistan 15
CO - Colombia 12
IN - India 12
NL - Olanda 12
PL - Polonia 12
ES - Italia 11
PY - Paraguay 11
TN - Tunisia 11
PE - Perù 10
LT - Lituania 9
AT - Austria 8
ID - Indonesia 8
JP - Giappone 8
AE - Emirati Arabi Uniti 7
BE - Belgio 6
DO - Repubblica Dominicana 6
MA - Marocco 6
AZ - Azerbaigian 5
KR - Corea 5
AO - Angola 3
BW - Botswana 3
DZ - Algeria 3
EU - Europa 3
JO - Giordania 3
KG - Kirghizistan 3
OM - Oman 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AU - Australia 2
BG - Bulgaria 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CL - Cile 2
HN - Honduras 2
IL - Israele 2
KW - Kuwait 2
KZ - Kazakistan 2
PS - Palestinian Territory 2
RS - Serbia 2
SA - Arabia Saudita 2
SN - Senegal 2
AM - Armenia 1
BO - Bolivia 1
CI - Costa d'Avorio 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
IE - Irlanda 1
IR - Iran 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MN - Mongolia 1
MV - Maldive 1
MY - Malesia 1
NP - Nepal 1
PH - Filippine 1
QA - Qatar 1
RO - Romania 1
SR - Suriname 1
SV - El Salvador 1
TW - Taiwan 1
UY - Uruguay 1
Totale 4.898
Città #
Dallas 683
Singapore 308
Chandler 201
Hong Kong 110
Beijing 88
Ashburn 86
Jacksonville 78
São Paulo 74
Princeton 58
Munich 50
Shanghai 44
New York 41
Los Angeles 35
Rio de Janeiro 35
Belo Horizonte 29
Nanjing 28
Dearborn 25
Ho Chi Minh City 23
Helsinki 21
Santa Clara 21
Sassari 21
Ann Arbor 20
Wilmington 20
Brasília 17
Brno 17
Porto Alegre 17
Campinas 16
London 16
Baghdad 15
Johannesburg 15
Nanchang 15
Curitiba 13
Fortaleza 13
Salvador 13
Brooklyn 12
Guarulhos 12
Tashkent 12
Boardman 11
Hanoi 11
Hebei 10
Mountain View 10
Warsaw 10
Joinville 9
Lima 9
Cagliari 8
Changsha 8
Columbus 8
Frankfurt am Main 8
Jiaxing 8
Nuremberg 8
Ribeirão Preto 8
Ribeirão das Neves 8
San Francisco 8
Santo André 8
Shenyang 8
Tokyo 8
Tunis 8
Amsterdam 7
Boston 7
Buffalo 7
Denver 7
Düsseldorf 7
Istanbul 7
Poplar 7
São Gonçalo 7
Tianjin 7
Washington 7
Asunción 6
Brussels 6
Canoas 6
Caruaru 6
Council Bluffs 6
Guayaquil 6
Haiphong 6
The Dalles 6
Toronto 6
Volta Redonda 6
Baku 5
Bauru 5
Campo Grande 5
Cape Town 5
Caracas 5
Carapicuíba 5
Criciúma 5
Cuiabá 5
Dhaka 5
Florianópolis 5
Manaus 5
Mauá 5
Montreal 5
Norwalk 5
Osasco 5
Ottawa 5
Piracicaba 5
Quito 5
Recife 5
Rome 5
Santa Maria 5
Seattle 5
Seoul 5
Totale 2.721
Nome #
A rare case of lupus-like syndrome during treatment with interferon β-1a. 209
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 173
Herv-k modulates the immune response in als patients 154
Personality traits predict perceived health-related quality of life in persons with multiple sclerosis 135
Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis 130
Cladribine vs other drugs in MS: Merging randomized trial with real-life data 119
Treadmill-virtual reality combined training program to improve gait in multiple sclerosis individuals 117
Multiple sclerosis-associated retrovirus and progressive disability of multiple sclerosis 117
Antihuman Endogenous Retrovirus Immune Response and Adaptive Dysfunction in Autism 116
Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study 116
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study 116
Proteomic analysis of CSF in multiple sclerosis patients and controls: a study in Sardinian population 116
Corpus callosum volumetrics and clinical progression in early multiple sclerosis 115
An innovative training program based on virtual reality and treadmill: effects on gait of persons with multiple sclerosis 113
First evidence of the cross-training effect in multiple sclerosis 112
ADEM o sclerosi Multipla: la comunicazione di una diagnosi difficile 111
Effect of Different Disease-Modifying Therapies on Humoral Response to BNT162b2 Vaccine in Sardinian Multiple Sclerosis Patients 108
Long-term trajectory of acquired demyelinating syndrome and multiple sclerosis in children 106
MSRV as a prognostic factor in Sardinian patients: 10-year follow-up 102
Cross-sectional analysis of the humoral response after SARS-CoV-2 vaccination in Sardinian multiple sclerosis patients, a follow-up study 102
Inflammation, infectious triggers, and Parkinson's disease 100
A six-week intensive treadmill training improves walking ability in MS patients with moderate disability 97
Natalizumab as treatment option of refractory epilepsy in multiple sclerosis. 96
Signs and symptoms of COVID-19 in patients with multiple sclerosis 95
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context 95
Virtual reality-treadmill training to improve gait in people with multiple sclerosis 94
A multi-element psychosocial intervention for early psychosis (GET UP PIANO TRIAL) conducted in a catchment area of 10 million inhabitants: study protocol for a pragmatic cluster randomized controlled trial 93
Intensive treadmill training improves gait in moderately impaired multiple sclerosis individuals 92
The Effect of Contralateral Strength Training on Muscle Weakness in People With Multiple Sclerosis: A Proof-of-Concept Case Series. 91
Influence of psychological and social factors on self perceived health-related quality of life in patients with multiple sclerosis 90
Tdp‐43 and herv‐k envelope‐specific immunogenic epitopes are recognized in als patients 89
Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination 87
Prolonged B-cell depletion after rituximab in AQP4-IgG-positive neuromyelitis optica spectrum disorder 82
Paresi del IX e X nervi cranici da ematoma parietale post-traumatico della carotide interna in paziente con crisi convulsiva 81
HERV-W/MSRV in the CSF significantly predicts the secondary progressive MS course upon 10-years follow-up 79
Sclerosi combinata del midollo, neuropatia ottica e deterioramento cognitivo post-resezione intestinale. Ruolo patogenetico della carenza di oligoelementi? 76
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register 75
First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study 71
Maternal multiple sclerosis is not a risk factor for neurodevelopmental disorders in offspring 70
Risk of disease relapse, safety and tolerability of SARS-CoV-2 vaccination in patients with chronic inflammatory neuropathies 69
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 69
RNA-binding proteins in autoimmunity: From genetics to molecular biology 66
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study 66
Network analysis of gut microbial communities reveal key genera for a multiple sclerosis cohort with Mycobacterium avium subspecies paratuberculosis infection 64
The role of ethnicity and native-country income in multiple sclerosis: the Italian multicentre study (MS-MigIT) 61
Mycobacterium avium subspecies paratuberculosis (MAP) infection, and its impact on gut microbiome of individuals with multiple sclerosis 61
Multiple Sclerosis Progression and Relapse Activity in Children 59
On a 5-year-old girl with multiple sclerosis treated with natalizumab 57
The Impact of Autistic Traits on Quality of Life and Symptom Severity in Multiple Sclerosis Patients: A Cross-Sectional Study 56
Identification of hsa_circ_0018905 as a New Potential Biomarker for Multiple Sclerosis 55
Determinants of self-perceived quality of life in mildly disabled multiple sclerosis patients: a cross-sectional study 52
Rasagiline Withdrawal Syndrome in Parkinson’s Disease 45
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study 40
Totale 4.960
Categoria #
all - tutte 20.945
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.945


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021109 0 0 0 0 0 4 22 1 32 24 18 8
2021/2022156 13 0 3 1 2 2 3 23 13 27 12 57
2022/2023366 29 48 6 61 43 47 1 34 56 20 12 9
2023/2024173 16 17 8 6 36 18 1 14 0 7 15 35
2024/20252.034 77 21 136 65 47 69 104 453 620 317 90 35
2025/20261.756 89 597 310 439 286 35 0 0 0 0 0 0
Totale 4.960